Morphea
☆ AI Dermatology — Free Service
An den 2022 Stiftung Warentest Resultater aus Däitschland war d'Zefriddenheet vum Konsument mam ModelDerm nëmme liicht manner wéi mat bezuelte Telemedizin Konsultatiounen.
An den 2022 Stiftung Warentest Resultater aus Däitschland war d'Zefriddenheet vum Konsument mam ModelDerm nëmme liicht manner wéi mat bezuelte Telemedizin Konsultatiounen.
D'Läsion vum Morphea erschéngt normalerweis als e atrophesche, pigmentéierten Fleck.
relevance score : -100.0%
ReferencesScleroderma ass eng selten Krankheet, déi d'Bindegewebe beaflosst, an d'Haut gestäerkt an heiansdo aner Deeler vum Kierper beaflosst. Et ginn zwou Haaptarten: systemic sclerosis, wat d'Hauthärtung an d'intern Organer involvéiert, an localized scleroderma, och bekannt als Morphea, déi normalerweis op d'Haut an d'Gewëss drënner bleift, mat engem benigne an selbstbegrenzende Kurs. Och wann lokaliséiert Sklerodermie ongewéinlech ass an hir Ursaach onkloer ass, suggeréiert déi rezent Fuerschung, datt et och intern Organer beaflosse kann an zu verschiddene Gesondheetsprobleemer féiere. Fréi Behandlung ass entscheedend, fir Komplikatiounen ze vermeiden, wéinst dem potenzielle Risiko vun localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Morphea, och bekannt als lokaliséiert Sklerodermie, ass eng selten Autoimmuner Krankheet, déi d'Bindegewebe beaflosst. Si kann op verschidde Manéier optrieden, an et ass net ganz heefeg, mat ongeféier 0,4–2,7 Fäll pro 100 000 Leit all Joer. Morphea gëtt dacks bei Kanner tëscht 2 a 14 Joer al gesinn, an et tendéiert d'Meedcher méi dacks wéi Jongë ze beaflossen.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea ass eng ganz rar Krankheet. Wéinst der Zesummesetzung vun der Foto kann de Algorithmus et fir Morphea verwiesselt hunn.